| Literature DB >> 31304979 |
Li Bai1, Saeha Shin2, Richard T Burnett3, Jeffrey C Kwong1,2,4,5, Perry Hystad6, Aaron van Donkelaar7, Mark S Goldberg8,9, Eric Lavigne10,11, Scott Weichenthal12, Randall V Martin7,13, Ray Copes2,4, Alexander Kopp1, Hong Chen1,2,3,4.
Abstract
Lung and female breast cancers are highly prevalent worldwide. Although the association between exposure to ambient fine particulate matter (PM2.5 ) and lung cancer has been recognized, there is less evidence for associations with other common air pollutants such as nitrogen dioxide (NO2 ) and ozone (O3 ). Even less is known about potential associations between these pollutants and breast cancer. We conducted a population-based cohort study to investigate the associations of chronic exposure to PM2.5 , NO2 , O3 and redox-weighted average of NO2 and O3 (Ox ) with incident lung and breast cancer, using the Ontario Population Health and Environment Cohort (ONPHEC), which includes all long-term residents aged 35-85 years who lived in Ontario, Canada, 2001-2015. Incident lung and breast cancers were ascertained using the Ontario Cancer Registry. Annual estimates of exposures were assigned to the residential postal codes of subjects for each year during follow-up. We used Cox proportional-hazards models adjusting for personal- and neighborhood-level covariates. Our cohorts for lung and breast cancer analyses included ~4.9 million individuals and ~2.5 million women, respectively. During follow-up, 100,146 incident cases of lung cancer and 91,146 incident cases of breast cancer were diagnosed. The fully adjusted analyses showed positive associations of lung cancer incidence with PM2.5 (hazard ratio [HR] = 1.02 [95% CI: 1.01-1.05] per 5.3 μg/m3 ) and NO2 (HR = 1.05 [95% CI: 1.03-1.07] per 14 ppb). No associations with lung cancer were observed for O3 or Ox . Relationships between PM2.5 and NO2 with lung cancer exhibited a sublinear shape. We did not find compelling evidence linking air pollution to breast cancer.Entities:
Keywords: ambient air pollution; breast cancer; incidence; lung cancer
Mesh:
Substances:
Year: 2019 PMID: 31304979 DOI: 10.1002/ijc.32575
Source DB: PubMed Journal: Int J Cancer ISSN: 0020-7136 Impact factor: 7.396